Skip to content

What is Phenylpiracetam Used For? Understanding its Applications and Effects

3 min read

Originally developed in the 1980s for Soviet cosmonauts to combat the stresses of spaceflight, Phenylpiracetam is a powerful nootropic with a wide range of purported uses. In Russia and Eastern Europe, it is an approved medication, but the question of what Phenylpiracetam is used for has a more complex answer for people in other parts of the world.

Quick Summary

Phenylpiracetam is a nootropic drug used in Russia for cognitive issues and fatigue. It is sought after for cognitive enhancement and physical performance but is unapproved by the FDA and banned by WADA.

Key Points

  • Russian Origin: Phenylpiracetam was developed in Russia for cosmonauts to improve physical and cognitive function under stress and is medically approved there.

  • Medically Prescribed in Some Regions: In Russia and Eastern Europe, it is prescribed for conditions like cerebrovascular deficiency, depression, anxiety, and fatigue.

  • Nootropic and Performance-Enhancing Use: Outside of medical settings, it is sought after for its potential to enhance cognitive function, memory, physical endurance, and motivation.

  • Dopaminergic and Cholinergic Action: Its mechanism of action involves acting as a dopamine reuptake inhibitor and modulating acetylcholine and AMPA receptors.

  • Unapproved in the U.S.: In the United States, Phenylpiracetam is not approved by the FDA for any medical or supplement use, and its sale for consumption is prohibited.

  • WADA Prohibited Substance: Due to its stimulant properties, Phenylpiracetam is banned for in-competition use by the World Anti-Doping Agency.

  • Potential Side Effects: Reported side effects include headaches, irritability, insomnia, and the development of tolerance over time.

  • Higher Potency than Piracetam: The addition of a phenyl group makes Phenylpiracetam more potent than its parent compound, Piracetam.

In This Article

Origins and Development

Phenylpiracetam, also known as Phenotropil or Carphedon, is a racetam drug developed in Russia in 1983. It's a modified version of piracetam with an added phenyl group, making it more potent and better able to cross the blood-brain barrier. Initially used by cosmonauts to enhance performance in extreme conditions, it was medically approved in Russia in 2003.

Approved Medical Uses in Russia and Eastern Europe

In Russia and some Eastern European countries, Phenylpiracetam is a prescription medication for various neurological and psychiatric conditions. It is used to improve blood flow in the brain after stroke, treat depression and anxiety symptoms, combat fatigue and apathy, and improve cognitive function in patients with chronic brain conditions. It also has anticonvulsant properties and is used as an add-on therapy for epilepsy.

Potential Nootropic and Performance-Enhancing Effects

Outside of approved medical uses, Phenylpiracetam is sometimes used as a "smart drug" for performance enhancement. Users report improved memory, learning, focus, and overall cognitive function. It is also believed to enhance physical endurance, reduce fatigue, and increase stress tolerance. Animal studies suggest its active component increases motivation.

The Science Behind Phenylpiracetam: Mechanism of Action

Phenylpiracetam's mechanism involves several pathways. Its (R)-enantiomer inhibits dopamine reuptake, increasing dopamine levels and contributing to its stimulant and pro-motivational effects. It also modulates neurotransmitter systems like acetylcholine and GABA and may potentiate AMPA receptors involved in memory. Increased cerebral blood flow is also thought to play a role in its cognitive effects.

Clinical Evidence and Research

Research, particularly in Russia, supports some uses. Studies show it improved motor and cognitive functions in stroke and encephalopathy patients. The (R)-enantiomer was explored for Parkinson's-related fatigue. Animal and limited human studies suggest antidepressant and anxiolytic effects. However, large-scale international studies are limited for many uses.

Phenylpiracetam vs. Piracetam

The phenyl group makes Phenylpiracetam more potent than Piracetam, with higher bioavailability and mild stimulant properties. While Phenylpiracetam is used in Russia for conditions like cerebrovascular deficiency, Piracetam is used for myoclonus and cognitive impairment internationally. Phenylpiracetam is banned by WADA, unlike Piracetam.

Feature Phenylpiracetam Piracetam
Potency Significantly more potent. Less potent.
Bioavailability Higher. Lower.
Stimulation Mild stimulant properties. Generally lacks stimulant properties.
Primary Uses (Russia) Cerebrovascular deficiency, depression, apathy, cognitive decline. Myoclonus, cognitive impairment (international).
WADA Status Prohibited. Not prohibited.

Legal Status and Regulatory Concerns

Phenylpiracetam is not FDA-approved in the U.S. and is considered an unapproved new drug, with warnings issued against sellers. While not a controlled substance, its sale for consumption is prohibited. WADA prohibits Phenylpiracetam for in-competition use due to its stimulant effects. In Russia, it's a prescription medication.

Side Effects and Safety Considerations

Potential side effects include rapid tolerance, insomnia, headaches, and irritability. Cardiovascular effects like increased blood pressure are possible. It can interact with other medications. Long-term safety data is limited, which is a concern.

Conclusion

Phenylpiracetam has approved medical uses in Russia for conditions like cerebrovascular insufficiency and depression, and is also used for cognitive and physical enhancement elsewhere. Its effects are linked to its interaction with dopamine and other neurotransmitters. However, its unapproved status in many countries, regulatory issues, and potential side effects require caution. Consultation with a healthcare professional is advised.

Phenylpiracetam - Wikipedia

Frequently Asked Questions

No, Phenylpiracetam is not approved by the FDA for medical or dietary supplement use in the US. While not a scheduled controlled substance, its sale and marketing for human consumption are unlawful, leading to regulatory warnings against sellers.

Common side effects may include sleep disturbances, headaches, increased irritability, and gastrointestinal discomfort. More serious side effects, such as increased heart rate and blood pressure, are possible, particularly with high doses or in sensitive individuals.

Phenylpiracetam is considered more potent than piracetam due to the addition of a phenyl group, which increases its bioavailability. It also has mild stimulant effects, whereas piracetam generally does not.

In Russia, Phenylpiracetam is medically approved for treating depression. However, evidence on its efficacy from international clinical trials is mixed, and it is not an approved treatment for depression in the US or most Western countries.

The World Anti-Doping Agency (WADA) has banned Phenylpiracetam for in-competition use because of its stimulant properties, which can give athletes an unfair performance-enhancing advantage.

Research and anecdotal reports suggest that Phenylpiracetam has potential cognitive-enhancing properties that may improve memory, learning, and focus. These effects are thought to be related to its interaction with neurotransmitters like dopamine and acetylcholine.

Yes, some users report developing a rapid tolerance to the effects of Phenylpiracetam. Many who use it suggest cycling the compound, taking breaks of a week or two, to maintain its effectiveness.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.